Premium Healthcare Products, Innovative Technology, Considerate Service Worldwide
Promisemed Medical Devices Inc. is devoted to offering premium healthcare products and considerate services with innovative technology in the fields of Diabetes Care, Injection & Infusion, Vascular Access, Interventional Ultrasound, and Interventional Endoscopy all around the world for both individuals and professionals.
Headquartered in Texas, USA, Promisemed owns 100,000-class purified workshops for production as well as pilot-scale experiments. Our products are with CE certificates and US FDA approval, with ISO 13485:2016, MDSAP, FMR Japan, China Class III Manufacturing License, and US FDA Establishment Manufacturing Facility.
Annually, Promisemed invests intensive capital into R&D, and we are committed to introducing more innovative products and providing better service to our partners worldwide.
Promisemed Milestones | The Path of Innovation Since 2013
- 2013.01: Promisemed was founded
- 2013.07: Obtained CE certificate and ISO 13485
- 2013.07: Launched pen needles and entered diabetes care field
- 2014.03: Launched safety lancets
- 2014.08: Obtained China manufacturing license
- 2015.09: Recognized as a National High-Tech Enterprise
- 2015.11: Launched safety pen needles
- 2017.05: Obtained the first FDA certificate
- 2018.09: Launched heel blood lancets
- 2018.10: Recognized as a State Enterprise Research Institute
- 2018.12: Launched the 2nd generation safety pen needles (DPN), one of the only two in the world
- 2019.07: New production base was completed
- 2019.08: Obtained MDSAP
- 2021.04: Launched syringes with fixed needles and entered infusion and injection field
- 2021.04: Obtained Japan FMR
- 2021.07: Obtained the first MDR certificate
- 2021.08: Launched biopsy needles and entered oncology field
- 2021.12: Launched Verifine® Ease Lancing Device
- 2022.03: Obtained NMPA approved product license
